Aclaris Therapeutics, Inc. financial data

Symbol
ACRS on Nasdaq
Location
701 Lee Road, Suite 103, Wayne, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 477 % -11.1%
Debt-to-equity 40.7 % +48.4%
Return On Equity -95.9 % -141%
Return On Assets -68.2 % -118%
Operating Margin -873 % -315%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108M shares +51.8%
Common Stock, Shares, Outstanding 108M shares +51.9%
Entity Public Float 76.1M USD -89.3%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 123M shares +71.9%
Weighted Average Number of Shares Outstanding, Diluted 123M shares +71.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.8M USD -47.6%
Cost of Revenue 2.38M USD -20.8%
Research and Development Expense 38M USD -45%
General and Administrative Expense 22.1M USD -17.7%
Costs and Expenses 163M USD +64.4%
Operating Income (Loss) -147M USD -118%
Nonoperating Income (Expense) 12M USD +59.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.4M USD -40.4%
Net Income (Loss) Attributable to Parent -135M USD -129%
Earnings Per Share, Basic -1 USD/shares -91.5%
Earnings Per Share, Diluted -1 USD/shares -91.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.4M USD +11.2%
Cash, Cash Equivalents, and Short-term Investments 181M USD +20.7%
Accounts Receivable, after Allowance for Credit Loss, Current 194K USD -40.3%
Assets, Current 104M USD -11.4%
Property, Plant and Equipment, Net 868K USD -32.9%
Intangible Assets, Net (Excluding Goodwill) 269K USD -96.1%
Other Assets, Noncurrent 2.99M USD -11.1%
Assets 189M USD +17.4%
Accounts Payable, Current 8.8M USD +21%
Employee-related Liabilities, Current 2.74M USD +28.2%
Accrued Liabilities, Current 11.4M USD +98%
Contract with Customer, Liability, Current 3.91M USD
Liabilities, Current 26.8M USD +71.1%
Contract with Customer, Liability, Noncurrent 18.2M USD
Deferred Income Tax Liabilities, Net 367K USD 0%
Operating Lease, Liability, Noncurrent 1.85M USD -21.8%
Other Liabilities, Noncurrent 1.85M USD -21.8%
Liabilities 57.4M USD +111%
Accumulated Other Comprehensive Income (Loss), Net of Tax 482K USD
Retained Earnings (Accumulated Deficit) -933M USD -16.9%
Stockholders' Equity Attributable to Parent 132M USD -1.56%
Liabilities and Equity 189M USD +17.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +37.3%
Net Cash Provided by (Used in) Financing Activities -275K USD
Net Cash Provided by (Used in) Investing Activities 19.1M USD +13.6%
Common Stock, Shares Authorized 400M shares +100%
Common Stock, Shares, Issued 108M shares +51.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.79M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.4M USD +11.2%
Deferred Tax Assets, Valuation Allowance 224M USD +15%
Deferred Tax Assets, Gross 226M USD +14.3%
Operating Lease, Liability 2.37M USD -16%
Depreciation 500K USD -37.5%
Payments to Acquire Property, Plant, and Equipment 43K USD -68.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -134M USD -130%
Lessee, Operating Lease, Liability, to be Paid 3.24M USD -29.6%
Property, Plant and Equipment, Gross 5.88M USD +1.12%
Operating Lease, Liability, Current 515K USD +14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 742K USD -12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 694K USD -9.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 637K USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three 760K USD -12.4%
Deferred Tax Assets, Operating Loss Carryforwards 120M USD +1.01%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 779K USD -12.5%
Additional Paid in Capital 1.06B USD +14.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 75K USD 0%
Depreciation, Depletion and Amortization 128K USD -47.3%
Share-based Payment Arrangement, Expense 12.5M USD +2.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%